Summary
This 8-K filing from Axon Enterprise, Inc. (formerly TASER International, Inc.) on November 27, 2013, primarily addresses the company's litigation strategy and recent settlement activity. Axon highlights the effectiveness of risk management strategies implemented in 2009, which have significantly reduced product liability cases, leading to expectations of substantial legal expense savings starting in the second half of 2014. The company generally adheres to a policy of not settling injury or death cases unless strategically beneficial, particularly for pre-2009 cases where litigation exposure and the risk of high jury verdicts warrant exceptions.
Key Highlights
- 1Axon has implemented effective risk management strategies since 2009, leading to a significant reduction in active product liability cases from 55 to 22 between Q3 2011 and Q3 2013.
- 2The company experienced zero new lawsuits in the third quarter of 2013, indicating success in mitigating litigation.
- 3Management anticipates significant savings in legal expenses starting in the second half of 2014 due to these strategies.
- 4Axon settled two pre-2009 product liability lawsuits in November 2013 for a combined total of $2.3 million due to litigation exposure exceeding insurance coverage and the risk of adverse jury verdicts.
- 5The expense related to these settlements will be recognized in the fourth quarter of 2013.
- 6Axon reaffirms its policy to aggressively defend litigation and generally not settle, with exceptions only in very limited and unusual circumstances.
- 7The filing includes forward-looking statements regarding litigation strategy, anticipated benefits, and outcomes, subject to various risk factors.